Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Computed tomography (CT) imaging of the kidney, ureter, and bladder permit accurate and prompt diagnosis or exclusion of traumatic injuries, without the need to move the patient to the fluoroscopy suite. Real-time review of imaging permits selective delayed imaging, reducing time on the scanner and radiation dose for patients who do not require delays. Modifying imaging parameters to obtain thicker slices and noisier images permits detection of contrast extravasation from the kidneys, ureters, and bladder, while reducing radiation dose on the delayed or cystographic imaging. The American Association for the Surgery of Trauma grading system is discussed, along with challenges and limitations.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.rcl.2015.02.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Multicontrast MR-Guided Diffusion Model for Ultra-Low-Dose Brain PET Denoising in Temporal Lobe Epilepsy.
IEEE J Biomed Health Inform
September 2025
Positron Emission Tomography (PET) is a critical imaging modality in nuclear medicine but requires radioactive tracer administration, which increases radiation exposure risks. While recent studies have investigated MR-guided low-dose PET denoising, they neglect two critical factors: the synergistic roles of multicontrast MR images and disease-specific denoising requirements. In this work, we propose a diffusion model that integrates T1-weighted, T2 fluid attenuated inversion recovery (T2 FLAIR), and hippocampal-optimized (T2 HIPPO) MR sequences to achieve ultra-low-dose PET denoising tailored for temporal lobe epilepsy (TLE).
View Article and Find Full Text PDFInvestigation of neutron stray fields close to the two meson targets of the PSI proton accelerator facility.
Radiat Prot Dosimetry
September 2025
Department of Radiation Safety and Security, Paul Scherrer Institute (PSI), Forschungsstrasse 111, 5232 Villigen, Switzerland.
The High-Intensity Proton Accelerator Facility at the Paul Scherrer Institute (PSI) accelerates protons to an energy of 590 MeV with currents up to 2.4 mA, i.e.
View Article and Find Full Text PDFRobot-assisted percutaneous coronary intervention: a prospective, multicenter, randomized controlled, non-inferiority clinical trial.
J Geriatr Cardiol
August 2025
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Key Laboratory of Precision Medicine of Coronary Atherosclerotic Disease, Clinical Center for Coronary Heart Disease, Capital Medical University, Beijing,
Objective: To evaluate the safety and effectiveness of robot-assisted percutaneous coronary intervention (R-PCI) compared to traditional manual percutaneous coronary intervention (M-PCI).
Methods: This prospective, multicenter, randomized controlled, non-inferior clinical trial enrolled patients with coronary heart disease who met the inclusion criteria and had indications for elective percutaneous coronary intervention. Participants were randomly assigned to either the R-PCI group or the M-PCI group.
Evaluation of the liver load index as a predictor of liver exposure in right breast radiotherapy.
Rep Pract Oncol Radiother
August 2025
Department of Electroradiology, Poznan University of Medical Sciences, Poznan, Poland.
Background: To compare doses deposited to the liver during right breast radiotherapy with static and dynamic radiotherapy techniques. The second aim was to introduce the liver load index (LLI), a novel index developed to estimate radiation exposure to the liver prior to treatment selection.
Materials And Methods: We prepared radiotherapy treatment plans for ten patients with right breast cancer.
Role and practical guidelines for the use of radiotherapy in neuroblastoma - a narrative review of literature and clinical trial protocols.
Rep Pract Oncol Radiother
August 2025
Department of Oncology, Wroclaw Medical University, Wroclaw, Poland.
Neuroblastoma is the most common extracranial solid tumor in children, requiring multidisciplinary treatment, including radiotherapy, which is primarily applied in the high-risk group to prevent disease progression. The review highlights indications for radiotherapy, its role in multimodal treatment, and addresses aspects of radiotherapy planning, including target volume definition, prescribed radiation doses, optimal timing for radiotherapy implementation, and potential side effects. Particular attention is drawn to the lack of consensus regarding the necessity of an additional radiation dose for persistent residual disease in the primary tumor and the irradiation of metastatic sites remaining after induction therapy.
View Article and Find Full Text PDF